Hinova`s HP518 Gets FDA Fast Track For AR+ Triple-Negative Breast Cancer
05 Jul 2024 //
PR NEWSWIRE
Hinova Receives FDA Proceed Authorization for its IND Application for HP518
06 Feb 2023 //
PR NEWSWIRE
05 Jul 2024 //
PR NEWSWIRE
06 Feb 2023 //
PR NEWSWIRE